In: Basic Research in Cardiology, 2015, vol. 110, no. 1, p. 1-17
|
In: The International Journal of Cardiovascular Imaging, 2015, vol. 31, no. 5, p. 915-926
|
In: European Radiology, 2015, vol. 25, no. 7, p. 2067-2073
|
In: Archives of Gynecology and Obstetrics, 2015, vol. 291, no. 6, p. 1213-1220
|
In: Interactive CardioVascular and Thoracic Surgery, 2018, vol. 26, no. 6, p. 977-984
|
In: Computational and structural biotechnology journal, 2019, vol. 17, p. 886-894
High-mobility Group Box 1 (HMGB1) is an abundant protein present in all mammalian cells and involved in several processes. During inflammation or tissue damage, HMGB1 is released in the extracellular space and, depending on its redox state, can form a heterocomplex with CXCL12. The heterocomplex acts exclusively via the chemokine receptor CXCR4 enhancing leukocyte recruitment. Here, we used...
|
In: Frontiers in immunology, 2018, vol. 9, p. 2185
Infiltrating immune cells are a key component of the tumor microenvironment and play central roles in dictating tumor fate, either promoting anti-tumor immune responses, or sustaining tumor growth, angiogenesis and metastasis. A distinctive microenvironment is often associated to different tumor types, with substantial differences in prognosis. The production of a variety of chemotactic...
|
In: Frontiers in immunology, 2018, vol. 9, p. 2118
Chemokine synergy-inducing molecules are emerging as regulating factors in cell migration. The alarmin HMGB1, in its reduced form, can complex with CXCL12 enhancing its activity on monocytes via the chemokine receptor CXCR4, while the form containing a disulfide bond, by binding to TLR2 or TLR4, initiates a cascade of events leading to production of cytokines and chemokines. So far, the...
|
In: International Journal of Legal Medicine, 2014, vol. 128, no. 1, p. 127-137
|
In: European Journal of Nuclear Medicine and Molecular Imaging, 2014, vol. 41, p. 91-103
|